Ameriprise’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-59,848
| Closed | -$907K | – | 3790 |
|
|
2019
Q4 | $907K | Buy |
59,848
+6,732
| +13% | +$58.1K | ﹤0.01% | 3096 |
|
|
2019
Q3 | $339K | Buy |
53,116
+19,241
| +57% | +$161K | ﹤0.01% | 3428 |
|
|
2019
Q2 | $323K | Buy |
33,875
+11,647
| +52% | +$125K | ﹤0.01% | 3466 |
|
|
2019
Q1 | $302K | Buy |
+22,228
| New | +$185K | ﹤0.01% | 3448 |
|
|
2018
Q1 | – | Sell |
-100,518
| Closed | -$2.79M | – | 3737 |
|
|
2017
Q4 | $2.79M | Buy |
100,518
+891
| +0.9% | +$23.6K | ﹤0.01% | 2480 |
|
|
2017
Q3 | $2.69M | Buy |
+99,627
| New | +$2.61M | ﹤0.01% | 2455 |
|
|
2017
Q2 | – | Sell |
-34,315
| Closed | -$1.17M | – | 3825 |
|
|
2017
Q1 | $1.17M | Buy |
+34,315
| New | +$1.11M | ﹤0.01% | 2822 |
|
|
2016
Q4 | – | Sell |
-110,031
| Closed | -$3.72M | – | 3983 |
|
|
2016
Q3 | $3.72M | Sell |
110,031
-3,469
| -3% | -$112K | ﹤0.01% | 2205 |
|
|
2016
Q2 | $3.32M | Buy |
113,500
+28,742
| +34% | +$793K | ﹤0.01% | 2230 |
|
|
2016
Q1 | $1.75M | Sell |
84,758
-8,159
| -9% | -$200K | ﹤0.01% | 2588 |
|
|
2015
Q4 | $3.21M | Buy |
92,917
+13,782
| +17% | +$396K | ﹤0.01% | 2334 |
|
|
2015
Q3 | $1.85M | Buy |
+79,135
| New | +$1.92M | ﹤0.01% | 2663 |
|
Ameriprise's DERM Position: Q1 2020 in Review
Ameriprise sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 59,848 shares — an estimated $907K sold.
Ameriprise first reported a position in DERM in Q3 2015 and held it in 12 quarters. The position peaked at $3.72M in Q3 2016. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Ameriprise reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Ameriprise sold 59,848 Dermira, Inc. shares in Q1 2020, an estimated $907K.
- Ameriprise first reported a position in Dermira, Inc. in Q3 2015 and held it in 12 quarters.
- Ameriprise's Dermira, Inc. position peaked at $3.72M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Ameriprise's 13F filing for Q1 2020, filed 15 May 2020.